Skip to main content
. Author manuscript; available in PMC: 2014 Mar 5.
Published in final edited form as: Ann Neurol. 2013 Mar 5;73(2):266–280. doi: 10.1002/ana.23788

Figure 9.

Figure 9

CAP recordings of lysolecithin-induced demyelinating lesions treated with VCPAL or vehicle. (A–C) Raw traces of recordings of slices from (A) a lesion treated with vehicle and HA; (B) a lesion treated with HA and 25 μM VCPAL; and (C) the uninjected contralateral hemisphere of the animal in A. Following recording, slices were fixed in paraformaldehyde then stained as whole-mounts with an anti-MBP antibody (white). (D) A slice from an animal injected with HA and vehicle. (E) A slice from an animal injected with HA and VCPAL. (F) Quantification of the ratios of averaged recordings of fast and slow latencies. Note that slices treated with VCPAL demonstrated significant recovery of fast latency transduction.